comparative between butorphanol and nalbuphine as to adjuvants to spinal bupivacaine in infra umbilical surgeries
Not Applicable
- Conditions
- Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene
- Registration Number
- CTRI/2019/04/018408
- Lead Sponsor
- Yawanth Reddy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients posted for lower abdominal, lower limb surgeries under spinal anaesthesia
Exclusion Criteria
Patients allergic to local anaesthetics, nalbuphine/ Butorphanol
ASA physical status III or more
Height <140cms and BMI >30 kg/m2
Patient contraindicated for spinal anaesthesia
Patient who had acute and chronic pain elements
Patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the duration of analgesia in terms of time to first analgesic requirement. <br/ ><br>Timepoint: Postoperatively <br/ ><br>
- Secondary Outcome Measures
Name Time Method To compare quality of analgesia measured in terms of total analgesic requirement . <br/ ><br> <br/ ><br>To compare pain scores, duration of motor blockade, perioperative hemodynamic parameters. <br/ ><br> <br/ ><br>To study the incidence of opioid related side effects in the two groups <br/ ><br>Timepoint: intra operatively and Postoperatively